Challenge The brand director in the lifecycle management division of a large pharmaceutical company was challenged to find new revenue opportunities for a cardiology drug that had reached maturity in...
Challenge A mid-sized pharmaceutical company acquired the U.S. rights for a product in a market with just one competitor, but was lacking the market knowledge to position the drug. Before starting...
Challenge The oncology team at a large pharmaceutical company was looking to optimize market position on several fronts: Defend its territory as a first-line therapy for indication #1 Uncover...
Challenge: The chief strategy officer at a large pharmaceutical company needs to have up-to-date knowledge regarding broad trends in immuno-oncology development activities. The chief strategy officer...
Case Study: Mapping the Clinical Path in Rheumatoid Arthritis with Real World Data The growing accessibility of healthcare Real World Data (RWD) has opened up previously unimaginable resources for...
Challenge The respiratory marketing team at a large pharmaceutical company was planning a launch market strategy for a new indication, and was looking for a deeper understanding of the therapy...
Validation and review of a patient-level simulation model for NICE submission.
Adaptation of a complex outcomes model for reimbursement submission to SMC.
Development of a detailed HEOR Road Map for our client's product, outlining evidence generation activities linked to themed key challenges and the product’s early value proposition.